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ABSTRACT 
Objective: Present investigation accounts for scientific evaluation of the plant Clerodendrum infortunatum L. for its medicinal efficacy which 
includes phytochemical screening and anticancer activities.  
Methods: Phytochemical screening of Clerodendrum infortunatum extracts was performed for the qualitative detection of reducing sugars, terpenoids, 
flavonoids, saponins, tannins, alkaloids, phlobatannins, steroids, amino acids and glycosides using standard procedures. The sulforhodamine B (SRB), in 
vitro cytotoxic assay, was used to investigate the anticancer activity of hexane, chloroform, ethyl acetate and ethanol extracts of leaves and roots of 
Clerodendrum infortunatum against T47D (Breast), PC-3 (prostate), A549 (lung) and HCT-116 (colon) cancer cell lines. 
Results: Secondary metabolites including alkaloids, flavonoids, terpenoids, steroids, tannins, and saponins are present in many extracts. Alkaloids 
and flavonoids found to be present in almost all the extracts. The best cytotoxic activity has been exerted by hexane of root exhibiting growth 
inhibition of 72.83 ± 0.44, 85.50 ± 0.29 and 68.17 ± 1.36 % against PC-3, A549 and HCT-116 at a concentration of 100 µg/ml. Further, hexane of root 
showed a moderate cytotoxic effect of 42.17 ± 0.17 % against T47D at 100 µg/ml. At similar concentration, the chloroform extract is also effective 
against these three cell lines showing 61.50 ± 0.76, 67.00±0.58, and 68.53 ± 0.80% growth inhibition against PC-3, A549 and HCT-116 cell lines 
respectively, whereas, T47D cancer cell line showed 46.43 ± 0.30 % growth inhibition. The results have indicated that all the leaf extracts, as well as 
ethyl acetate and ethanol extracts of root, have exhibited a poor response ( ≤ 40 %). 
Conclusion: The present findings suggest that the Clerodendrum infortunatum extracts are rich in alkaloid, flavonoids and terpenoids. The hexane 
and chloroform root extracts of Clerodendrum infortunatum possess significant anticancer activities which may be due to the presence of these 
phytochemical groups. 
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INTRODUCTION 
Cancer is one of the most malignant diseases in which deregulating 
propagation of abnormal cells plague and disrupt contiguous tissues 
[1]. Both developed and developing countries express serious public 
health problems in terms of cancer. It is a mortal disease and 
presently, about one in five of all deaths is because of cancer [2]. 
Normal human cells proliferate for a fixed number of generations 
and then enter a condition of replicative senescence, but cancer cells 
can multiply endlessly [3]. There are 12.7 million cases of cancer and 
7.6 million cancer deaths recorded in 2008; of these 64% of deaths 
exist in the economically developing countries [4]. The detectable 
tumors can be evaluated by surgical means, but it may put down 
nest of cancer cells in the patient, which continue to flourish while 
radiation therapy provides an inaccurate healing as it can 
exterminate both cancer and normal cells. The limited success of 
these therapies in the treatment of cancer indicates that there is an 
imperative need of alternative strategies in cancer management [5]. 
The universal fatality rate may increase by nearly 80 % by 2030, 
with enormous probability in low-and-middle-income countries 
devoid of instant action cited by the World Health Organization 
(WHO). Novel therapeutic alternatives to analyze for cancer treatment 
are of elevated priority for most of the pharmaceutical industries and 
independent research organizations worldwide. Significant research 
activity is committed to the innovation of more potent treatments 
while reducing their toxic side effects. So, there is a precondition of 
cancer chemotherapy for the development of selective drugs that can 
kill malignant tumor cells or render them benign without affecting 
normal cells which may eventually direct to attain the goal [6]. 
The practical access to this difficulty is the use of terrestrial plants as 
an application for drug development. Plants have played a leading role 
in the development of sophisticated traditional medicine systems. 
About 80% of the populations in some Asian and African countries 
rely on traditional medicine for main health care as estimated by the 
WHO. The 70–80% of the populations of developed countries also 
decides on plant products as a complementary medicine. 
Different species of Clerodendrum genus have been traditionally used 
over the centuries, and their antioxidant, and hepatoprotective 
potential have already been proved [7-9]. C. infortunatum is very 
common throughout the plains of India. The leaves are slightly bitter, 
cure inflammation, skin diseases and good in smallpox [10]. The plant 
found to contain triterpenes, steroids, and flavonoids [11, 12]. The 
antioxidant [13], antimicrobial [14], anti-malarial [15], anthelmintic 
[16] and analgesic [17] activities of the plant have further created an 
upsurge in investigations on the plant. Therefore, the objective of the 
present study was designed to evaluate the anticancer potential of 
different extracts of C. infortunatum against different cancer cell lines. 
MATERIALS AND METHODS 
Plant source and extract preparation 
The plant C. infortunatum (Verbenaceae) was collected from the 
roadside of Bhadra River Channels, Shimoga, Karnataka, India. The 
plant was authenticated by Dr. V. Krishna, Professor, Department of 
Biotechnology, Kuvempu University, Karnataka, who is one of the 
known taxonomists. The leaves and roots (after cutting into small 
pieces) were shade dried for several days. The plant material was 
then oven dried for 24 h at a considerably lower temperature (40 
°C) for moisture free and better grinding. The air-dried and finely 
ground leaf (1000g) and root (500g) material of the plant was 
extracted in a Soxhlet apparatus successively with hexane, 
chloroform, ethyl acetate and ethanol from low polarity to high 
polarity. A suitable solvent was added to the flask, and the setup was 
heated under reflux. The steam of the solvent which, when contacts 
with the material will dissolve metabolites and brings back 
metabolites to the flask. The extracts were filtered, pooled and 
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concentrated to dryness under reduced pressure in a rotary 
evaporator (Buchi, Flawil, Switzerland) to yield dried hexane, 
chloroform, ethyl acetate and ethanol extracts. The extracts so 
obtained from each of solvents were labeled and yield was 
calculated in terms of grams/weight of the powdered material. 
Solubility tests of plant extracts  
Solubility tests were carried out for the analysis of solubility of crude 
extracts in different solvents like hexane, chloroform, ethyl acetate, 
acetone, DMSO, ethanol, methanol, water, 1N NaOH, and 1N HCl. 
Phytochemical analysis of extracts 
Phytochemical screening of C. infortunatum extracts was performed 
for the qualitative detection of reducing sugars, terpenoids, 
flavonoids, saponins, tannins, alkaloids, phlorotannins, steroids, 
amino acids and glycosides using standard procedures [18, 19].  
Chemicals 
The chemicals utilized in this analysis comprises RPMI-1640 
(Roswell Memorial Park Institute), Minimum Essential Medium, fetal 
calf serum, trypsin, trypan blue, ethanol, penicillin, streptomycin, 
gentamycin, dimethyl sulfoxide (DMSO), sulforhodamine B (SIGMA), 
adriamycin, mitomycin-C, paclitaxel, 5-fluorouracil (5-FU; Sigma 
Chemical Co., St Louis, MO, USA), phosphate buffer saline (Merck, 
Darmstadt, Germany); trichloroacetic acid (TCA), distilled water, 
sodium hydroxide, Tris-EDTA buffer, Tris buffer (Hi-Media, Mumbai, 
India), acetic acid, sodium bicarbonate, hydrochloric acid (Rankem, 
New Delhi, India), isopropanol (Sisco, Mumbai, India), and Tris-
acetate-EDTA buffer. All other chemicals used in this study were 
purchased locally and were of analytical grade. 
Cell lines and cell culture 
The human cancer cell lines used in this study, including T47D 
(Breast), PC3 (prostate), A549 (lung) and HCT-116 (colon) were 
obtained from the National Center for Cell Science, Pune, India. The 
properties of the cell lines under investigation as well as their 
culture conditions are summarized in table 1. 
The cells were sustained in a CO2 incubator with 5% CO2 and 95% 
humidity and supplemented with desired medium and 10% fetal 
bovine serum (FBS). Glutamine (2 mM), penicillin (100 units/ml), 
and streptomycin (100 mg/ml) were also added to the medium to 
1×final concentration from a 100 × stock. After attaining the 
confluent growth, the cells were trypsinized using Trypsin-EDTA 
(0.25%) and the number of cells required to perform the assay were 
seeded into sterile 96-well plates. Then the plates were incubated in 
a CO2 incubator with 5% CO2 and 95% humidity [20, 21]. 
  
Table 1: Review of cell lines under investigation, their origin, characteristics and culture conditions 
Cell Line Description Seeding density (Per cm2) Growth media ER status P53Status Doubling time (h) 
T47D Breast 30,000 DMEM + Mu 32 
PC-3 Prostate 50,000 DMEM + Null 40 
A-549 Lung 40,000 RPMI 1640 + Wt 22 
HCT-116 Colon 30,000 RPMI 1640 + Wt 21 
 
Cytotoxic assay preparation 
Trypan blue exclusion method has been employed to determine the 
viability of the cells. Concisely, 100 µl of cell suspension (10,000 
cells) of each cell line was plated in each well of 96-well plates, and 
incubated for 24 h at 37 °C in a humidified CO2 (5%) incubator. The 
growth inhibitory activity of the hexane, chloroform, ethyl acetate 
and ethanol extracts of both leaf and root were evaluated against 
four cell line panels consisting of T47D (Breast), PC3 (prostate), 
A549 (lung) and HCT-116 (colon) using the SRB assay[22]. The 
lyophilized extracts were dissolved in DMSO and filtrated by 0.2 µm 
cellulose acetate sterile filter. After 24 h of incubation time of cell 
lines, an amount of 1, 10 and 100 µg/ml of each extract was added. 
Several standard anticancer drugs were used as positive control for 
comparison. The drugs include Adriamycin (10µM) against T47D, 
mitomycin (1µM) against PC-3, paclitaxel (1 µM) against A549 and 5-
Fluorouracil (20µM) against HCT-116 were added as a positive control 
against desired cancer cell lines per well and incubated for 48 h. 
Sulpho rhodamine B assay 
After 48 h of incubation with test samples, each well was fixed with 
50 µl of 50% trichloroacetic acid solution to stop the reaction and 
incubated at 4 oC for 1 h followed by washing with distilled water. 
Excess water was drained off and the plates were air-dried for 24 h. 
Then cells were stained with 50 µl of 0.4% SRB solution in 1% acetic 
acid for 30 m at room temperature (27±2 oC). After incubation, the 
unbound SRB solution was discarded, and the plates were washed 
with 1% acetic acid. The plates were air-dried, and 100 µl of 10 mM 
Tris-base solution (pH 10.5) was added to each well to solubilize the 
dye and shaken for 30 min on a mechanical shaker. The optical 
density (OD) at 540 nm was determined by the micro plate reader 
(Bio-Rad, Model 680, USA). All the investigation was performed in 
triplicates. The percentages of the cell growth inhibition were 
determined using the following equation:  
% Growth inhibition = 100 −
 OD (test sample) −  OD (blank)
OD (Control) − OD (blank)
× 100 
Statistical analysis 
The data from biological assays were subjected to the One-way 
analysis of variance (ANOVA) procedures which were presented as 
mean±SEM. P ≤ 0.01 was considered as significant. 
RESULTS 
Physical characteristics and percentage yield of extracts 
Extraction (as the term is pharmaceutically used) is the separation 
of medicinally active portions of plants using selective solvents 
through standard procedures. The products so obtained from 
plants are relatively complex mixtures of metabolites, in liquid or 
semisolid state or (after removing the solvent) in dry powder 
form, and are intended for oral or external use. These include 
classes of preparations known as decoctions, infusions, fluid 
extracts, tinctures, pilular (semisolid) extracts or powdered 
extracts. The percent yield of both leaf and root extracts obtained 
from C. infortunatum and their description is outlined in table 2 
and 3. 
 
Table 2: Percent yield (w/w) and physical characteristics of C. infortunatum Leaf extracts 
Samples Quantity used for extraction Nature of the extract % Yield 
Powder (g) Solvent (ml) 
Hexane 1000 250 Black Sticky mass 3.0 
Chloroform 1000 250 Dark Solid 2.0 
Ethyl acetate 1000 250 Slightly light green solid mass 3.5 
Ethanol 1000 250 Dark sticky brown paste 20.0 
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Table 3: Percent yield (w/w) and physical characteristics of C. infortunatum root extracts 
Samples Quantity used for extraction Nature of the extract % Yield 
Powder (g) Solvent (ml) 
Hexane 500 250 Light yellow mass 1.0 
Chloroform 500 250 Brown sticky paste 1.5 
Ethyl acetate 500 250 Orange red paste with acidic smell 1.0 
Ethanol 500 250 Red paste with acidic smell 4.0 
 
Table 4: Phytoconstituents present in the leaf extracts of C. infortunatum L. 
Phytoconstituents  Hexane extract Chloroform extract Ethyl acetate extract Ethanol extract 
Alkaloids +ve +ve +ve -ve 
Flavonoids +ve +ve +ve +ve 
Terpenoids +ve -ve +ve -ve 
Steroids -ve -ve -ve +ve 
Tannins -ve -ve -ve +ve 
Phlobtannins -ve -ve -ve -ve 
Saponins -ve -ve -ve +ve 
Carbohydrates +ve +ve +ve +ve 
Glycosides +ve +ve +ve -ve 
Amino acids -ve -ve -ve +ve 
(+ve): Present; (-ve): Absent. 
 
Table 5: Phytoconstituents present in the root extracts of C. infortunatum L. 
Phytoconstituents  Hexane extract Chloroform extract Ethyl acetate extract Ethanol extract 
Alkaloids +ve +ve +ve -ve 
Flavonoids -ve +ve +ve +ve 
Terpenoids +ve +ve -ve +ve 
Steroids -ve -ve +ve +ve 
Tannins -ve -ve -ve +ve 
Phlobtannins -ve -ve -ve -ve 
Saponins -ve -ve -ve +ve 
Carbohydrates +ve +ve +ve +ve 
Glycosides -ve -ve -ve -ve 
Amino acids -ve -ve -ve -ve 
(+ve): Present; (-ve): Absent. 
 
Table 6: Cytotoxic effect of leaf extracts of plant on different cancer cell lines 
Tissue Breast Prostate lung Colon 
Cell line type T47D PC-3 A549 HCT-116 
S. No. Sample Conc. (µg/ml) % Growth inhibition 
1. Hexane 1 15.73±0.64** NT NT 1.93±0.52** 
10 20.87±0.35** 1.73±0.43** 1.37±0.20** 3.03±0.15** 
100 28.43±0.49** 13.93±0.61** 43.83±0.55** 22.10±1.15** 
2. Chloroform 1 NT NT NT NT 
10 NT NT NT NT 
100 NT 14.20±0.44** 35.70±0.65** 1.67±0.24** 
3. Ethyl acetate 1 21.10±0.49** NT NT 5.83±0.90** 
10 20.87±0.58** NT 2.37±0.33** 12.83±0.27** 
100 24.43±0.32** 11.33±0.33** 21.23±0.67** 12.27±0.68** 
4. Ethanol 1 NT NT NT NT 
10 NT NT NT NT 
100 18.07±0.58** 11.87±0.24** 10.13±0.09** 11.27±0.37** 
5. Adriamycin 10µM 63.27±0.37 - - - 
6. Mitomycin 1µM - 67.60±0.56 - - 
7. Paclitaxel 1µM - - 76.73±0.82 - 
8. 5-Fluorouracil 20µM - - - 50.60±0.31 
NT: Non-toxic, Values are expressed as mean±SE of three values. **P<0.01; **p values were calculated comparing the experimental results to 
standard results. 
 
From the above tables, it is estimated that the yield of hexane, 
chloroform, ethyl acetate and ethanol extracts of the leaf was found to be 
3.0, 2.0, 3.5 and 20.0% respectively. Likewise, the yield of hexane, 
chloroform, ethyl acetate and ethanol extracts of root was found to be 
1.0, 1.5, 1.0 and 4.0 % respectively. It is evident from the above tables 
that extraction with ethanol in both leaf and root yields the highest 
amount of extracts. 
Qualitative detection of phytochemical constituents  
All the solvent extracts from leaf and root were subjected to 
preliminary qualitative phytochemical analysis. The various groups 
of phytochemical constituents found to be present in these extracts 
are shown below (table 4 and 5). The presence of groups of all these 
different extracts includes alkaloids, flavonoids, terpenoids, steroids, 
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tannins and carbohydrates. This analysis revealed that the plant 
possesses alkaloids, flavonoids, carbohydrates in high concentration. 
In vitro cytotoxic activity of plant extracts 
The in vitro cytotoxic effect of eight extracts of leaf and root (four 
from each part) derived from C. infortunatum were evaluated on 
four human cancer cell lines from different tissues of origin, namely; 
T47D (Breast), PC-3 (prostate), A549 (lung) and HCT-116 (colon) 
cancer cell lines. The cytotoxic activity of the extracts was compared 
with the activity of standard anticancer drugs. The results suggest 
that among the four different root extracts, hexane and chloroform 
showed a significant cytotoxic activity against PC-3, A549 and HCT-
116 cell lines used and had shown moderate activity against the 
T47D cell line, whereas, the ethanol and ethyl acetate extracts did 
not show promising activity when compared to the respective 
standards used. The results of cytotoxic effects of both leaf and root 
extracts are summarized in table 6 and 7. The best antiproliferative 
activity has been exerted by hexane of root exhibiting growth 
inhibition of 72.83±0.44, 85.50±0.29 and 68.17±1.36 % against PC-3, 
A549 and HCT-116 at a concentration of 100µg/ml. Further, hexane 
showed a moderate cytotoxic effect of 42.17±0.17 % against T47D at 
100µg/ml. At a similar concentration the chloroform extract is also 
effective against these three cell lines showing 61.50±0.76, 
67.00±0.58, and 68.53±0.80 % growth inhibition against PC-3, A549 
and HCT-116 respectively, whereas, T47D cancer cell line showed 
46.43±0.30 % growth inhibition. The results have indicated that all 
the leaf extracts, as well as ethyl acetate and ethanol root, have 
exhibited a poor response ( ≤40%). 
Percent growth inhibition resulting from the standard drugs on 
different cell lines used in this study is found between 50 and 77%. 
The cytotoxic effect of some extracts is comparatively more than 
that of standard drugs. 
 
Table 7: Cytotoxic effect of root extracts of plant on different cancer cell lines 
Tissue Breast Prostate Lung Colon 
Cell line type T47D PC-3 A549 HCT-116 
S. No. Sample Conc. (µg/ml) % Growth inhibition 
1. Hexane 1 NT NT NT NT 
10 NT 25.33±0.34** 2.00±0.58** 14.60±0.31** 
100 42.17±0.17** 72.83±0.44** 85.50±0.29** 68.17±1.36** 
2. Chloroform 1 NT 1.33±0.33 NT NT 
10 NT 23.00±0.58 NT 6.83±0.22 
100 46.43±0.30** 61.50±0.76** 67.00±0.58** 68.53±0.80** 
3. Ethyl acetate 1 12.27±0.82** NT NT NT 
10 14.33±0.88** NT 12.00±0.583 NT 
100 26.43±0.260** 29.80±0.42** 14.00±0.58** 15.07±0.41** 
4. Ethanol 1 26.43±0.47** NT NT NT 
10 31.23±0.67** NT NT NT 
100 39.83±0.44** 11.33±0.88** NT 5.00±0.58** 
5. Adriamycin 10µM 63.27±0.37 - - - 
6. Mitomycin 1µM - 67.60±0.56 - - 
7. Paclitaxel 1µM - - 76.73±0.82 - 
8. 5-Fluorouracil 20µM - - - 50.60±0.31 




Cancer is the prominent origin of death in efficiently developed 
countries and second largest death in developing countries [23]. It is 
estimated that new cases of cancer will rise approximately 25% in 
each decade, aiming 24 million new cases per year in the year 2050 
[24]. The current threat linked with presently existing drugs 
comprises selectivity, toxicity, resistance, and development of a 
secondary malignancy. The downsides of these anticancer agents 
have encouraged the examination of the novel, competent and well 
resistant drugs against cancer, as natural products, mainly from 
plants. Keeping this in mind, the present investigations have been 
carried out to screen the cytotoxic potential of extracts of C. 
infortunatum against different human cancer cell lines. 
The plant material was subjected for Soxhlet extraction using 
solvents of appropriate polarity following the principles of ‘like 
dissolves like’ thus non-polar solvents were used to solubilize most 
lipophilic compounds (e. g., alkanes, fatty acids, pigments, waxes, 
sterols, few terpenoids, alkaloids). Medium polarity solvents were 
used to extract compounds of intermediate polarity (e. g., some 
alkaloids, flavonoids) while more polar solvents were used for more 
polar compounds (e. g., flavonoid, glucosides, quaternary alkaloids, 
tannins, etc.). Based on this principle, four different solvents have 
been used with increasing polarity, i.e., hexane, chloroform, ethyl 
acetate and ethanol for successive extraction. 
Phytochemical screening of C. infortunatum extracts was performed to 
determine the presence of phytoconstituents such as: alkaloids, 
flavonoids, terpenoids, steroids, carbohydrates, tannins, saponins, 
glycosides, amino acids. Among these groups alkaloids and flavonoids 
are found to be very rich in these extracts followed by terpenoids, 
while as, saponins, tannins, and steroids are present only in ethanol 
extract. The presence of these groups may direct to comprehend the 
potent cytotoxic activity of the plant. Earlier reports on medicinal 
plants suggest that alkaloids [25]and flavonoids [26] extensively play a 
vital role in the toxicity of cancer cells. 
In this study hexane, C. infortunatum root is found to be significantly 
toxic against PC-3 (prostate), A549 (lung) and HCT-116 (colon) 
cancer cell lines exhibiting growth inhibition of 72.83±0.44, 
85.50±0.29 and 68.17±1.36% respectively at a concentration of 
100µg/ml in the SRB assay compared to the standard drug. 
Likewise, hexane, chloroform root extract at the same concentration 
of 100µg/ml also exhibited considerable growth inhibition of 
61.50±0.76, 67.00±0.58 and 68.53±0.80% against same cancer cell 
lines. It is pertinent to note that, the percentage inhibition is greater 
than the standard drug used. Both of these extracts exerted 
moderate cytotoxic activity against the T47D cell line. The growth 
inhibition may be due to the presence of non-polar and medium 
polar type of compounds. Hexane and chloroform revealed higher 
cytotoxic activity than other extracts used which could be due to the 
high content of alkaloids and flavonoids or may be of terpenoids. 
Interestingly, both extracts which showed highest anticancer activity 
are from the root parts of C. infortunatum and unveil the presence of 
alkaloids, flavonoids as well as terpenoids.  
There are many earlier reports suggesting the biological activities of 
several alkaloids viz., the anticancer effects of vinblastine [27], 
camptothecin (CPT), a famous topoisomerase-I (TopI) inhibitor [28]. 
Similarly, berberine inhibits the proliferation of multiple cancer cell 
lines by inducing cell cycle arrest at the G1 or G2/M phases and by 
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apoptosis [29, 30, 31]evodiamine exhibits anticancer activities both 
in vitro and in vivo by inducing the cell cycle arrest or apoptosis, 
inhibiting the angiogenesis, invasion, and metastasis in a variety of 
cancer cell lines [32, 33]. Piperine and matrine are also considered 
to be potent anticancer alkaloids [34, 35].  
The role of flavonoids in cancer prevention indicates that flavonoids 
have important effects on cancer chemoprevention and 
chemotherapy [36]. The various flavonoids which showed 
anticancer activity on different human cancers include flavanones, 
daidzein, genistein, quercetin, luteolin are effective against breast 
cancer[37, 38]. Flavone, quercetin have also been proved to be 
potent against human lung cancer [39, 40]. Catechin, epicatechin, 
quercetin, kaempferol, luteolin, genistein, apigenin, myricetin, 
silymarin possess significant effect against human prostate cancer 
[41-43]. The flavonoids which are considered to be very effective 
against human colon cancer exclude flavone, quercetin, genistein, 
anthocyanin [44, 45].  
In addition, of alkaloids and flavonoids, the diverse array of terpenoid 
structures and functions has provoked increased interest in their 
commercial use. Terpenoids have been found to be useful in the 
prevention and therapy of several diseases, including cancer [46]. 
Some Species of Clerodendrum genus that have been investigated in 
the anticancer study and have resulted in the innovation of 
promising drugs include C. serratumSpreng. [47, 48], C. bungei Study 
[49, 50], C. calamitosumL. [51]. Other species of Clerodendrum 
including C. phlomidis, C. inerme, C. colebrookianum and C. 
trichotomum also possess significant cytotoxic activity [52, 53]. 
Some investigations also identified the important cytotoxic activity 
of leaf extracts of C. viscosum [54].  
Based on all this information the alkaloids and flavonoids or 
terpenoids present in C. infortunatum may be the actual source of 
cytotoxic effect against the human cancers investigated in this study. 
CONCLUSION 
Thus, the findings of this investigation suggest that the C. 
infortunatum extracts are rich in alkaloids, flavonoids, and 
terpenoids. The hexane and chloroform root extracts of the plant 
possess significant anticancer activities in vitro against PC-3 
(prostate), A549 (lung) and HCT-116 (colon) cell lines which may be 
due to the presence of these alkaloids, flavonoids, and terpenoids. 
Hence, C. infortunatum could be considered as promising plant 
possessing anticancer properties. Further, extensive studies are 
required to identify, isolate and characterize specific phyto 
molecules responsible for bioactivities observed in this study and 
their inherent mechanism(s) of action. 
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